| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Frederik Bartels, Birgit Baumgartner, Annette Aigner, Graham Cooper, Astrid Blaschek, Eva Maria Wendel, Annikki Bertolini, Michael Karenfort, Matthias Baumann, Robert Cleaveland, Andreas Wegener-Panzer, Steffen Leiz, Michela Salandin, Peter Krieg, Tobias Reindl, Markus Reindl, Carsten Finke, Kevin Rostás. Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Acute Disseminated Encephalomyelitis. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 2. 2023-02-08. PMID:36754833. |
acute disseminated encephalomyelitis (adem) is the most common phenotype in pediatric myelin oligodendrocyte glycoprotein (mog) antibody-associated disease. |
2023-02-08 |
2023-08-14 |
Not clear |
| Davide Cossu, Kazumasa Yokoyama, Tamami Sakanishi, Leonardo A Sechi, Nobutaka Hattor. Bacillus Calmette-Guérin Tokyo-172 vaccine provides age-related neuroprotection in actively induced and spontaneous experimental autoimmune encephalomyelitis models. Clinical and experimental immunology. 2023-02-06. PMID:36745025. |
groups of young and mature adult female c57bl/6j mice were bcg-vaccinated 1 month prior or 6 days after active eae induction using myelin oligodendrocyte glycoprotein (mog)35-55 peptide. |
2023-02-06 |
2023-08-14 |
mouse |
| Magdalena Lerch, Angelika Bauer, Markus Reind. The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023-02-02. PMID:36729854. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an acquired inflammatory demyelinating disease with optic neuritis (on) as the most frequent clinical symptom. |
2023-02-02 |
2023-08-14 |
human |
| Yuki Imai, Hiroyuki Onoue, Kyoko Numahata, Tomohiro Ogawa, Yasuhisa Akaiwa, Tomoyuki Miyamot. [Absence of cortical lesions after the first seizure in a patient with anti-myelin oligodendrocyte glycoprotein-associated cortical encephalitis]. Rinsho shinkeigaku = Clinical neurology. 2023-02-01. PMID:36725012. |
serum anti-myelin oligodendrocyte glycoprotein (mog) antibody was subsequently detected, and prednisolone was added to treat the flair-hyperintense lesions in anti-mog antibody associated encephalitis with seizures (flames). |
2023-02-01 |
2023-08-14 |
Not clear |
| Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palac. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. 2023-01-27. PMID:36706773. |
serum antibodies directed against myelin oligodendrocyte glycoprotein (mog) are found in patients with acquired cns demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. |
2023-01-27 |
2023-08-14 |
Not clear |
| Yuqing Wu, Hao Zhou, Xiaojiao Ci, Liuyu Lin, Da Zhang, Jie L. Clinical characteristic of myelin oligodendrocyte glycoprotein antibody associated cortical encephalitis in adults and outcomes following glucocorticoid therapy. Frontiers in aging neuroscience. vol 14. 2023-01-23. PMID:36688157. |
to describe the clinical and radiological features, as well as outcomes following glucocorticoid therapy and recurrence in adults suffering from cortical encephalitis associated with myelin oligodendrocyte glycoprotein (mog) antibody. |
2023-01-23 |
2023-08-14 |
Not clear |
| Marianna Spatola, Omar Chuquisana, Wonyeong Jung, Joseph A Lopez, Eva-Maria Wendel, Sudarshini Ramanathan, Christian W Keller, Tim Hahn, Edgar Meinl, Markus Reindl, Russell C Dale, Heinz Wiendl, Douglas A Lauffenburger, Kevin Rostásy, Fabienne Brilot, Galit Alter, Jan D Lüneman. Humoral signatures of MOG-antibody-associated disease track with age and disease activity. Cell reports. Medicine. 2023-01-20. PMID:36669487. |
myelin oligodendrocyte glycoprotein (mog)-antibody (ab)-associated disease (mogad) is an inflammatory demyelinating disease of the cns. |
2023-01-20 |
2023-08-14 |
human |
| Chadi Azar, Grace Akiki, Sara F Haddad, Anthony Kerbage, Fady Haddad, Gabrielle Macaro. High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge. Multiple sclerosis journal - experimental, translational and clinical. vol 9. issue 1. 2023-01-13. PMID:36636582. |
the phenotypic spectrum of myelin oligodendrocyte glycoprotein (mog)-igg associated disorders (mogad) has broadened in the past few years, and atypical phenotypes are increasingly recognized. |
2023-01-13 |
2023-08-14 |
Not clear |
| Memoona Nasir, Ruth Obrocki, Magdalini Krommyda, Naveed Male. Conus medullaris syndrome as a presenting feature of MOG-associated disease. Practical neurology. 2023-01-13. PMID:36639247. |
mr imaging showed an abnormality in the lowest part of the spinal cord as a first presentation of myelin oligodendrocyte glycoprotein (mog)-associated disease. |
2023-01-13 |
2023-08-14 |
Not clear |
| Francesca Bosello, Damiano Marastoni, Francesca Benedetta Pizzini, Chiara Zaffalon, Andrea Zuliani, Giulia Turri, Sara Mariotto, Erika Bonacci, Emilio Pedrotti, Massimiliano Calabres. Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review. Journal of neuroimmunology. vol 375. 2023-01-09. PMID:36621074. |
we describe the case of a 74 years-old patient who developed a myelin oligodendrocyte glycoprotein (mog) antibody-associated unilateral retrobulbar optic neuritis a few weeks after paucisymptomatic covid-19 disease and, subsequently, after the resolution of the optic neuritis, an acute inflammatory demyelinating polyneuropathy. |
2023-01-09 |
2023-08-14 |
Not clear |
| Wenjing Song, Yang Yao, Heling Zhang, Xin Hao, Liping Zhou, Zhixiao Song, Tiantian Wei, Tianyan Chi, Peng Liu, Xuefei Ji, Libo Zo. Sigma-1 Receptor Activation Improves Oligodendrogenesis and Promotes White-Matter Integrity after Stroke in Mice with Diabetic Mellitus. Molecules (Basel, Switzerland). vol 28. issue 1. 2023-01-08. PMID:36615583. |
only pre084 treatment for 21 d could improve this white-matter injury; increase axon and myelin density; decrease demyelination; and increase the expressions of myelin regulator 2'-3'-cyclic nucleotide 3'-phosphodiesterase (cnpase) and myelin oligodendrocyte protein (mog) (which was expressed by mature oligodendrocytes), the number of nerve/glial-antigen 2 (ng2)-positive cells, and the expression of platelet-derived growth factor receptor-alpha (pdgfrα), all of which were expressed by oligodendrocyte progenitor cells in mice with diabetes and focal cerebral ischemia. |
2023-01-08 |
2023-08-14 |
mouse |
| Alanood E Elterefi, Mahfoud Y Elbashari, Amani Alzaabi, Mohamed E Abouelnaga, Hesham Eiss. Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies. Cureus. vol 14. issue 12. 2023-01-05. PMID:36601183. |
combined central and peripheral demyelination in a patient of multifocal motor neuropathy and positive anti-myelin oligodendrocyte glycoprotein (mog) antibodies. |
2023-01-05 |
2023-08-14 |
Not clear |
| Alanood E Elterefi, Mahfoud Y Elbashari, Amani Alzaabi, Mohamed E Abouelnaga, Hesham Eiss. Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies. Cureus. vol 14. issue 12. 2023-01-05. PMID:36601183. |
myelin oligodendrocyte glycoprotein (mog) antibodies have been identified in central nervous system inflammatory demyelinating disorders (mog antibody disease), inclusive of optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis. |
2023-01-05 |
2023-08-14 |
Not clear |
| Michael Quagliata, Francesca Nuti, Feliciana Real-Fernandez, Kalina Kirilova Kirilova, Federica Santoro, Alfonso Carotenuto, Anna Maria Papini, Paolo Rover. Glucopeptides derived from myelin-relevant proteins and hyperglucosylated non-typeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: a step forward in the identification of native autoantigens in multiple sclerosis. Journal of peptide science : an official publication of the European Peptide Society. 2023-01-04. PMID:36597597. |
we prepared two glucosylated peptides derived from the human myelin proteins, i.e., oligodendrocyte-myelin glycoprotein (omgp) and reticulon-4 receptor (rtn4r), selected by a bioinformatic approach for their conformational homology with csf114(glc), a designed β-turn antigenic probe derived from myelin oligodendrocyte glycoprotein (mog), a glycoprotein present in the cns. |
2023-01-04 |
2023-08-14 |
human |
| Debananda Sahoo, Anil Dash, Anupam Dey, Sujata Dev. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association. BMJ case reports. vol 15. issue 12. 2023-01-03. PMID:36593613. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated longitudinally extensive transverse myelitis (letm) and primary sjogren syndrome: a rare association. |
2023-01-03 |
2023-08-14 |
Not clear |
| Nazeer Ahmed, Jaya Kumari, Warda Shahnawaz, Hafsa Sami, Fnu Naina, Mohammad Hasan, Sheeza Eru. A unilateral FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) case from a developing country: A case report. Annals of medicine and surgery (2012). vol 84. 2022-12-30. PMID:36582878. |
the new clinical and radiological entity of the myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is known as the flames syndrome. |
2022-12-30 |
2023-08-14 |
Not clear |
| B Thomas Bäckströ. A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis. Journal of visualized experiments : JoVE. issue 190. 2022-12-26. PMID:36571423. |
although animal models do not accurately mimic all of these contrasting human disease phenotypes, there are eae models that reflect some of the different clinical manifestations of ms. for example, myelin oligodendrocyte glycoprotein (mog)-induced eae in c57bl/6j mice mimics human ppms, while myelin proteolipid protein (plp)-induced eae in sjl/j mice resembles rrms. |
2022-12-26 |
2023-08-14 |
mouse |
| Naoki Yamamoto, Hajime Ikenouchi, Yoshiki Takai, Kaoru Endo, Masashi Aok. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease With False-Positive Results in SARS-CoV-2 Antigen Tests: A Case Report. Cureus. vol 14. issue 11. 2022-12-21. PMID:36540506. |
due to positive serum and cerebrospinal fluid myelin oligodendrocyte glycoprotein (mog) antibodies, we made the diagnosis of mog-associated disease. |
2022-12-21 |
2023-08-14 |
Not clear |
| Sara CartaÁlvaro Cobo Calvo, Thaís Armangué, Albert Saiz, Christian Lechner, Kevin Rostásy, Markus Breu, Matthias Baumann, Romana Höftberger, Ilya Ayzenberg, Carolin Schwake, Maria Sepulveda, Eugenia Martínez-Hernández, Gemma Olivé-Cirera, Georgina Arrambide, Mar Tintoré, Raphael Bernard-Valnet, Renaud A Du Pasquier, Fabienne Brilot, Sudarshini Ramanathan, Kathrin Schanda, Alberto Gajofatto, Sergio Ferrari, Elia Sechi, Eoin P Flanagan, Sean J Pittock, Vyanka Redenbaugh, Markus Reindl, Romain Marignier, Sara Mariott. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study. Neurology. 2022-12-16. PMID:36526426. |
although the diagnosis of myelin oligodendrocyte glycoprotein antibody associated disease (mogad) is based on serum mog antibodies (mog-abs) positivity, patients with coexisting or restricted mog-abs in the csf have been reported. |
2022-12-16 |
2023-08-14 |
Not clear |
| Jorge Guzmán, Francisco Vera, Bernardita Soler, Reinaldo Uribe-San-Martin, Lorena García, Adolfo Del-Canto, Andrea Schlatter, Mauricio Salazar, Fernando Molt, Karla Ramirez, José Marín, Carolina Pelayo, Juan Pablo Cruz, Sebastián Bravo-Grau, Claudia Cárcamo, Ethel Ciamp. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases. Multiple sclerosis and related disorders. vol 69. 2022-12-15. PMID:36521387. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad) is an emerging disorder recognized as a clinical entity distinct from multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorders (nmosd-aqp4+), and its phenotypic spectrum continues to expand. |
2022-12-15 |
2023-08-14 |
Not clear |